Roche launches Institute of Human Biology to accelerate breakthroughs in R & D by unlocking the potential of human model systems

The Institute of Human Biology aimsto better predict which drug candidates are safe and most effective in patients by evolving and increasing the use of human model systems.Human model systems are miniature living ' replicas ' of human tissues and organs that also have the potential to reduce reliance on animal testing.The institute brings together scientists from academia and industry to lead the broad adoption of human model systems in pharmaceutical R&D as well as in clinical practice.Basel, 4 May 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the Institute of Human Biology (IHB) focussing on advancing research in the field of human model systems such as organoids. Leveraging human model systems, the institute aims to accelerate drug discovery and development by improving the understanding of how organs function and how diseases develop. Ultimately, this will help to bring medicines to patients faster. These efforts will also enable early testing of which drug candidates are safe and which molecules would work best for each patient.Human model systems are miniature 2D or 3D living ' replicas ' of human tissues and organs that scientists create from human stem cells. By mirroring human and disease biology more accurately than animal models, they can also help reduce the reliance on animal testing. In addition, human model systems may enable the discovery of new human biology (in health and disease) and identification of drug targets that are imp...
Source: Roche Media News - Category: Pharmaceuticals Source Type: news